Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer.

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Risk Factors for Doxorubicin-lnduced Congestive Heart Failure

1979 • 2,308 citations

A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung Cancer

1991 • 260 citations

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer

1975 • 207 citations

Phase-II study of Navelbine in advanced breast cancer.

1989 • 132 citations

The synthesis of Navelbine prototype of a new series of vinblastine derivatives.

1989 • 112 citations

A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer

1983 • 92 citations

Does chemotherapy improve survival in advanced breast cancer? A statistical overview

1988 • 90 citations

Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors.

1985 • 80 citations

Progress in chemotherapy for metastatic breast cancer.

1992 • 72 citations

Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study.

1991 • 72 citations

Chemotherapy of advanced breast cancer: outcome and prognostic factors

1993 • 65 citations

General motors cancer research foundation awards. Charles F. Kettering Award. Stepwise progress in the treatment of disseminated cancers

1983 • 31 citations

Chemotherapeutic approaches to advanced breast cancer.

1988 • 15 citations